ATE76306T1 - Pharmazeutische loesungen die dimethylsulfoxid enthalten. - Google Patents

Pharmazeutische loesungen die dimethylsulfoxid enthalten.

Info

Publication number
ATE76306T1
ATE76306T1 AT86301657T AT86301657T ATE76306T1 AT E76306 T1 ATE76306 T1 AT E76306T1 AT 86301657 T AT86301657 T AT 86301657T AT 86301657 T AT86301657 T AT 86301657T AT E76306 T1 ATE76306 T1 AT E76306T1
Authority
AT
Austria
Prior art keywords
solutions containing
pharmaceutical solutions
solution
skin
containing dimethylsulfoxide
Prior art date
Application number
AT86301657T
Other languages
English (en)
Inventor
Edmund Sandborn
Original Assignee
Dimethaid Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dimethaid Research Inc filed Critical Dimethaid Research Inc
Application granted granted Critical
Publication of ATE76306T1 publication Critical patent/ATE76306T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT86301657T 1984-05-14 1986-03-07 Pharmazeutische loesungen die dimethylsulfoxid enthalten. ATE76306T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA000454281A CA1236029A (en) 1984-05-14 1984-05-14 Pharmaceutical solutions comprising dimethyl sulfoxide
EP19860301657 EP0235424B1 (de) 1984-05-14 1986-03-07 Pharmazeutische Lösungen die Dimethylsulfoxid enthalten

Publications (1)

Publication Number Publication Date
ATE76306T1 true ATE76306T1 (de) 1992-06-15

Family

ID=4127865

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86301657T ATE76306T1 (de) 1984-05-14 1986-03-07 Pharmazeutische loesungen die dimethylsulfoxid enthalten.

Country Status (5)

Country Link
US (2) US4575515A (de)
EP (1) EP0235424B1 (de)
AT (1) ATE76306T1 (de)
CA (1) CA1236029A (de)
DE (1) DE3685432D1 (de)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1236029A (en) * 1984-05-14 1988-05-03 Edmund Sandborn Pharmaceutical solutions comprising dimethyl sulfoxide
GB8517299D0 (en) * 1985-07-09 1985-08-14 Salim A S M Dermatologically active substances
IT1197056B (it) * 1986-08-01 1988-11-25 Intercos Italiana Pomata per mascherare difetti della pelle e cicatrici
DE3632359A1 (de) * 1986-09-24 1988-04-07 Troponwerke Gmbh & Co Kg Arzneimittelzubereitungen
DE3706421A1 (de) * 1987-02-27 1988-09-08 Robugen Gmbh Arzneimittel zur behandlung viraler erkrankungen
EP0348507A4 (en) * 1987-12-23 1990-12-27 Poltav Med Stomatolog Inst Pharmaceutical preparation for individual prophylaxis of venereal diseases and curing urogenital trichomoniasis
US5059603A (en) * 1989-06-12 1991-10-22 Centuries Laboratories, Inc. Method and composition for treating impotence
US5061724A (en) * 1989-07-18 1991-10-29 Sheldon Gertner Method for treating arthritically inflamed body joints, particularly joints having gouty arthritis
US5091379A (en) * 1989-08-31 1992-02-25 Du Pont Merck Pharmaceutical Company Topical antinflammatory compositions with minimal systemic absorption
EP0711181A1 (de) * 1993-07-28 1996-05-15 Pfizer Inc. Behandlung der psoriasis
US6113893A (en) * 1993-07-28 2000-09-05 Pfizer Inc. Psoriasis treatment
US5665378A (en) * 1994-09-30 1997-09-09 Davis; Roosevelt Transdermal therapeutic formulation
US6492420B2 (en) * 1995-03-10 2002-12-10 Photocure As Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
NZ303251A (en) * 1995-03-10 2000-10-27 Photocure Asa Use of esters of 5-aminolevulinic acid as photosensitising agents in photochemotherapy
US6992107B1 (en) * 1995-03-10 2006-01-31 Photocure Asa Esters of 5-aminolevulinic acid and their use as photosensitizing compounds in photochemotherapy
US7530461B2 (en) * 1995-03-10 2009-05-12 Photocure Asa Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
GB9700396D0 (en) 1997-01-10 1997-02-26 Photocure As Photochemotherapeutic compositions
US20040121023A1 (en) * 1998-11-02 2004-06-24 Victor Stevens Composition to alleviate pain and topical method of applying same
US6159977A (en) * 1998-11-16 2000-12-12 Astan, Inc. Therapeutic anti-fungal nail preparation
US20040048376A1 (en) * 2000-04-10 2004-03-11 Benoit Chabot Methods for modulating splicing and/or alternative splicing, and for identifying alternatively spliced units in genes
GB0018528D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Compounds
GB0018527D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Composition
DE60316810T2 (de) 2002-08-02 2008-07-17 Ab Science 2-(3-aminoaryl)amino-4-aryl-thiazole und ihre verwendung als c-kit inhibitoren
US8450302B2 (en) * 2002-08-02 2013-05-28 Ab Science 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
US20040126343A1 (en) * 2002-12-26 2004-07-01 Garshowitz Solomon David Nail drug delivery
US7132452B2 (en) * 2003-03-10 2006-11-07 Fang-Yu Lee Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection
PL1684750T3 (pl) * 2003-10-23 2010-10-29 Ab Science 2-Aminoarylooksazole jako inhibitory kinazy tyrozynowej
US20060223788A1 (en) * 2005-03-29 2006-10-05 Cathcart Clifton H Analgesic composition for topical use
EP2361624A1 (de) * 2005-04-04 2011-08-31 AB Science Oxazolderivate und Ihre Anwendung als Tyrosinkinase Inhibitoren
US20060281822A1 (en) * 2005-04-20 2006-12-14 Cardinal Associates, Inc. Treatment and prevention of elevated homocysteine
US20100087546A1 (en) * 2005-04-20 2010-04-08 Biogenic Innovations, Llc Use of dimethyl sulfone (msm) to reduce homocysteine levels
CA2617934A1 (en) * 2005-08-05 2007-02-15 Nuvo Research Inc. Transdermal drug delivery formulation
US8435224B2 (en) 2005-09-12 2013-05-07 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (DMSO) and related compounds
EP2324838A1 (de) 2005-09-12 2011-05-25 Abela Pharmaceuticals, Inc. Zusammensetzungen mit Dimethyl-Sulfoxid
JP5399072B2 (ja) * 2005-09-12 2014-01-29 アベラ ファーマスーティカルズ インコーポレイテッド ジメチルスルホキシド（ｄｍｓｏ）若しくは関連化合物、又はそれに関連する臭気を除去するシステム
US8480797B2 (en) * 2005-09-12 2013-07-09 Abela Pharmaceuticals, Inc. Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
ITLO20060004A1 (it) * 2006-08-08 2008-02-09 River Pharma Srl "lapille" e una nuova invenzione avente per oggetto una nuova combinazione chimica stabile per uso cosmetico e farmaceutico contenente come ingredienti attivi l'acido alfa-lipoico ed il dimetilsulfossido, in grado di migliorare l'assorbimento, la bio
JP5432716B2 (ja) 2006-10-17 2014-03-05 ヌーボ リサーチ インコーポレイテッド ジクロフェナクゲル
US20100254965A1 (en) * 2006-10-24 2010-10-07 Board Of Regents ,The University Of Texas System Adenosine Signaling in Diagnosis, Treatment, and Prevention of Priapism and Erectile Dysfunction
EP2211837B1 (de) 2007-06-08 2013-11-13 Troikaa Pharmaceuticals Ltd Nichtwässrige topische lösung aus diclofenac und verfahren zu ihrer herstellung
US20100100060A1 (en) * 2008-10-17 2010-04-22 Novartis Ag Applicator for pharmaceutical product and method of using same
BRPI0921494A2 (pt) * 2008-11-03 2018-10-30 Prad Reasearch And Development Ltd método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
US8618164B2 (en) 2009-03-31 2013-12-31 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
US8546450B1 (en) 2009-03-31 2013-10-01 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
TWI418347B (zh) * 2009-10-21 2013-12-11 Yung Shin Pharm Ind Co Ltd 治療疱疹病毒感染的方法
AU2010313253B2 (en) 2009-10-30 2015-02-19 Abela Pharmaceuticals, Inc. Dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) formulations to treat osteoarthritis
TWI523852B (zh) 2010-01-12 2016-03-01 Ａｂ科學公司 經取代之唑衍生物、含彼之組合物及其用途
TW201202232A (en) 2010-01-28 2012-01-16 Ab Science Treatment of GIST with masitinib
CA2828086C (en) 2010-03-10 2018-07-31 Nuvo Research Inc. Foamable formulation
US9408867B2 (en) 2011-05-11 2016-08-09 Veloce Biopharma, Llc Antifungal compositions for the treatment of skin and nails
AU2012288900B2 (en) 2011-07-27 2016-10-06 Ab Science Selective protein kinase inhibitors
US10813897B2 (en) * 2011-12-27 2020-10-27 Cmpd Licensing, Llc Composition and method for compounded therapy
ES2734357T3 (es) 2012-02-17 2019-12-05 Veloce Biopharma Llc Composiciones antifúngicas para uso en el tratamiento de enfermedades de la piel
US20140113970A1 (en) 2012-10-22 2014-04-24 Mallinckrodt LLC Covidien Dispensing system
CA2943316A1 (en) 2014-03-24 2015-10-01 Ab Science Diazaspiroalkaneone-substituted oxazole derivatives as spleen tyrosine kinase inhibitors
KR20190032629A (ko) 2015-01-20 2019-03-27 벨로체 바이오파르마 엘엘씨 신규한 요오드포 조성물 및 사용 방법
ES2796276T3 (es) 2015-02-05 2020-11-26 Ab Science Compuestos con actividad antitumoral
EP3144307A1 (de) 2015-09-18 2017-03-22 AB Science Neue oxazol derivaten als syk kinasehemmer
WO2017172603A1 (en) 2016-03-28 2017-10-05 Tioga Research, Inc. Topical formulation
EP4034136A4 (de) * 2019-06-19 2023-07-05 The United States Government As Represented By The Department Of Veterans Affairs Formulierungen mit lithium zur behandlung von gichtarthropathie
EP4138806A4 (de) 2020-05-01 2024-04-24 Achelon, Inc. Schnell wirkende topische anästhetische formulierungen
US20250099369A1 (en) 2023-09-27 2025-03-27 Andros Pharmaceuticals Co., Ltd. Topical delivery compositions comprising non-steroidal anti-inflammatory drugs

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1001075A (en) * 1963-12-09 1976-12-07 Stanley W. Jacob Pharmaceutical compositions containing dialkyl sulfoxides
US3549770A (en) * 1963-12-09 1970-12-22 Crown Zellerbach Corp Therapeutic administration of effective amounts of dimethyl sulfoxide to human and animal subjects
BE644613A (de) * 1963-12-09 1964-07-01
US3740420A (en) * 1967-11-28 1973-06-19 Crown Zellerbach Corp Pharmaceutical compositions with dimethyl sulfoxide
US3551554A (en) * 1968-08-16 1970-12-29 Crown Zellerbach Corp Enhancing tissue penetration of physiologically active agents with dmso
US3711602A (en) * 1970-10-30 1973-01-16 Crown Zellerbach Corp Compositions for topical application for enhancing tissue penetration of physiologically active agents with dmso
US3743727A (en) * 1970-11-16 1973-07-03 Crown Zellerbach Corp Enhancing tissue penetration of certain antimicrobial agents with dimethyl sulfoxide
EP0051163A3 (de) * 1980-11-03 1983-02-16 Dr. Franz Köhler Chemie KG Intramuskulär schmerzlos anwendbare 4-Dimethylaminophenol Hydrochlorid-Lösung und Verfahren zu deren Herstellung
US4353896A (en) * 1981-06-08 1982-10-12 Levy Michael A Penetrating topical medicament
US4369190A (en) * 1981-06-23 1983-01-18 Schulte Thomas L Analgesic composition and use thereof to ameliorate intractable pain
GR81250B (en) * 1983-12-22 1985-11-19 American Home Prod Menthol enhancement of transdermal drug delivery
CA1236029A (en) * 1984-05-14 1988-05-03 Edmund Sandborn Pharmaceutical solutions comprising dimethyl sulfoxide

Also Published As

Publication number Publication date
CA1236029A (en) 1988-05-03
EP0235424A1 (de) 1987-09-09
US4575515A (en) 1986-03-11
US4652557A (en) 1987-03-24
DE3685432D1 (de) 1992-06-25
EP0235424B1 (de) 1992-05-20

Similar Documents

Publication Publication Date Title
DE3685432D1 (de) Pharmazeutische loesungen die dimethylsulfoxid enthalten.
DK154987A (da) Farmaceutisk praeparat med forlaenget frigoerelse og fremstilling deraf
PH24867A (en) A method of treating conditions associated with photodamaged skin by using pharmaceutical compositions containing p(22-(5,6,7,8 tetrahydro-5,5,8,8-tetramethyl-2-naphtyl)propenyl)phenylsulfone and derivatives thereof
ATE94380T1 (de) Anti-akne-zusammensetzung.
BR9406746A (pt) Composto processo para sua preparaçao preparado farmacêutico uso de um composto processo para a obtençao da inibiçao de trombina em um organismo humano ou animale fragmento estrutural
FR2544984B1 (fr) Pommade dermique et dermatologique a large spectre d'activite, et son procede de preparation
DE69315927D1 (de) Kosmetische Zusammensetzung, die einen Lipidstoff und eine Hydroxy - oder Ketofettsäure enthält
DE3681358D1 (de) Substituierte oxindol-3-carboxamine als entzuendungshemmendes und schmerzstillendes mittel.
FI904494A7 (fi) Diagnoosi ja monistusmenetelmiä aluke-kohde-epäparin eliminoimiseksi alukkeen 3'-päässä
IT1256697B (it) Medicamenti per trattare condizioni infiammatorie o per analgesia.
DE68909958D1 (de) Phenoxyessigsäure-Derivate, ihre Herstellung, pharmazeutische Zusammensetzungen, die sie enthalten, und deren Verwendung.
KR910000158A (ko) 의약용 화합물 및 그것의 사용방법
DE69222318D1 (de) Hautpflegemittel
FR2598320B1 (fr) Compositions pharmaceutiques hydrosolubles contenant de l'ubiquinone en tant que principe actif, utiles dans differentes applications therapeutiques
BR9001484A (pt) Composicao inseticida e acaricida com efeito aperfeicoado,processo para aperfeicoar o efeito de uma substancia ativa inseticida
ATE69550T1 (de) Salicylsaeurehaltiges mittel gegen schuppende hauterkrankungen.
BR9304780A (pt) Composto, processo para preparar o composto, composição farmacêutica e uso
AU604418B2 (en) Cosmetic composition
FI823817A7 (fi) Nitroimidatsoliyhdisteitä ja näppyjen hoidossa käyttökelpoisia seoksia.
IT1143921B (it) Derivati di acidi alcanoici dotati di proprieta' terapeutiche e procedimento per la loro preparazione
ATE28630T1 (de) Substituierte benzolsulfonsaeureester, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ES2072869T3 (es) Uso de derivados de la 1,4-dihidropiridina en el tratamiento del alcoholismo.
ATE105563T1 (de) Retinsaeureester von l-cladinos, verfahren zu deren herstellung und ihre verwendung in der human- oder veterinaermedizin und in der kosmetik.
NL7903434A (nl) Derivaten van benzoylfenoxyalkaancarbonzuren met anti- lipemische en anticholesterolemische werking, alsmede farmaceutische preparaten die zo'n verbinding bevatten.
FI843695A7 (fi) Insuliini-johdannaisia, joissa B 30-asema on modifioitu, menetelmiä niiden valmistamiseksi ja niiden käyttö sekä sokeritaudin hoitoon tarkoitettuja lääkeaineita.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee